Brief Reports: PDF OnlyCOVID-19 in Neonates and Infants Progression and RecoveryNg, Khuen Foong MBBS(UM), MRCPCH(UK), PGcert (Genomic Medicine)*; Bandi, Srini MBBS, MD, FRCPCH, MSc (Infectious Diseases), MSc (Healthcare Leadership)*; Bird, Paul William BSc (Hons), MRes, MSc†; Wei-Tze Tang, Julian PhD, FRCPath‡Author Information *Paediatric Department, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom †Clinical Microbiology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom ‡Respiratory Sciences, University of Leicester, Leicester, United Kingdom. Accepted for publication April 27, 2020. The authors have no funding or conflicts of interest to disclose. Address for correspondence: Khuen Foong Ng, MBBS(UM), MRCPCH(UK), PGcert (Genomic Medicine), Paediatric Department, University Hospitals of Leicester NHS Trust, Infirmary Square, Leicester LE1 5WW, United Kingdom. E-mail: email@example.com. The Pediatric Infectious Disease Journal: May 6, 2020 - Volume Online First - Issue - doi: 10.1097/INF.0000000000002738 Free PAP Metrics Abstract Between March 10, 2020 and April 17, 2020, of 8/70 (11.4%) SARS-CoV-2 positive infants that presented, 5/8 (63%) developed fever, 4/8 (50%) had lower respiratory tract involvement, 2/8 (25%) had neutropenia and thrombocytosis, and 4/8 infants (50%) were treated for suspected sepsis with broad-spectrum antibiotics. Only 1/8 (13%) required pediatric intensive care. All patients were eventually discharged home well. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.